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The capsid protein VP2 of budgerigar fledgling disease virus (BFDV) contains two sequences (residues 309-3 IS and 334-340) which are homologous 
to the prototypic nuclear Iocalization scqueno; (NLS) of the simian virus 40 T-antigen. Using recombinant potential NLS-B-galactosidase fusion 
proteins we identified amino acid residues 303-317 (VPKRKRKLPT) to be the NLS of BFDV capsid proteins VP2 and VP3. Microfluorometry 
studies show that the BFDV-VP2 signal is considerably more efficient irn nuclear transport kinetics, than the NLS of SV40-VP2, corresponding 
to amino acid residues 317-326 (PNKKKRM LSR). 
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1. INTRODIJCTION 2. MATERIALS AND METHODS 
Budgerigar fledgling disease virus (BFDV) and Si- 
mian ,virus 40 (SV40) are both members of the polyoma 
virus subgroup of the papova l/irus family. The icosahe- 
dral capsid structure of these viruses consists ofstructu- 
ral proteins VPl, VP2 and VP3 [l]. Among these VP2 
and VP3 are closely related, since VP3 is identical to the 
C-terminal 234 amino acids of the VP2 protein’s 352 
residues, in SV40. The structure of BFDV viral proteins 
is very similar in general, but shows two clusters of basic 
amino acid residues (BFDV-VI?2 residues 309-315 and 
32&-340, respectively), instead of one in SV40 which is 
conserved in all polyoma viruses [2]. In the case of 
SV40-VP2, this region i: s necessary and sufficient for 
nuclear localization [3-5J and as a nuclear localization 
signal (NLS) it shows considerable similarity to the pro- 
totype NLS of SV4Q T-antigen [6,7]. The structure of 
NLSs and potential mtxhanisms of their function have 
recently been rcvieweri by Roberts [Q Silver [9] and 
Garcia-Bustos et al. [lo], In order to determine the NLS 
of BFDV-VP2 and to compare it with the NLS ;>f SV40- 
VP2, we constxcted recombinant proteins in which the 
two presumptive NLS segments of BFDV-VP2 and the 
single one of SV40.VP2 were inserted into the amino 
terminus of E. cofi ,P-galactosidase. 
2.1. Constrrrcrion and expression of NLS-lacZ hybrids 
To create N-terminal NLS-/&galactosidase fusion genes, appro- 
priate oliganmcleotides were synthetized on an Applied Biosystems 
Synthetizer (Weiterstadt, Germany) and inserted in an KppnI-HindIII 
partially (digested and gel purified vector fragment of pPR24 [lt], 
Hybrid ktcZ genes were characterized by restriction analysis and ex- 
pressed under p,ac promoter control in the presence of 0.5 mM IPTG 
(Boehringer Mannheim), overnight at 37°C. Expressed fusion prote- 
ins (see Fig. 1) showed B-galactosidase activity, at molecular masses 
of 117 kDa monomer. 
2.2. Prorein puriJicalion 
Purification of the fusion proteins was as described previously [ 1 l- 
131 via affinity chromatography on p-amino-benzyl-/j’-D-galactosi- 
dase.sepharosc (Sigma, Deisenhofen, Germany). Fusion proteins were 
conr:cntrated in the nresencc of PBS or inicction buffer (48 mM 
K,HPO,, I4 mM NafP,PO,, 45 mM KH,POi, pH 7,2) on ckntricon 
30 (Arnicon, Witten, Germany). Protein concentration was between 
0.5-6,5 mg/ml. 
2,3. Morwnn!~(m cells atld nlicroiujectiot~ 
R&t hepatoma tissue culture cells (HTC) and Vero cells used for the 
microinjcction experiments were cultured in DMEM medium in the 
presence of 10% fetal Wlf serum. In the case of HTC, polykaryons 
wcrc formed by treatment ofconfluent monolaycrs with polyethylene 
glycol (PEG; Boehringer Mannheim), which has the advantage that 
the cells are not able subsequently to undergo mitosis [14]. 
Correspondme and preserr t address: H.-P. Rihs, Bcrufsgcnos- 
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For determining the subcellular localization of injected fusion pro- 
teins a previously described histochcmical assay [12,13,15] was used, 
This assay makes use of the ,&galactosidase activity of the hybrid 
proteins. After microinjection, culture dishes with microinjcctcd cells 
were kept in the incubator for difrercnt times, bcforc they were fixed 
and labeled with X-gal. During an incubation period over 6-16 h 
-depending on b-galactosidasc activity - the blue colour dcvelopcd 
at various time points and its subccllular location could bc arialyscd 
by microscopy (see Fig, 2), For microfluorimrtric studies the fusion 
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Fig. 1. Scheme of the fusion proteins constructed in the present study. 
The N- and C-terminal amino acid residues of BFDV-VP2 OK and 
SV40-VP2 q are indicated by numbers. Empty boxes correspond to 
linker regions. P-Gal a; P-galactosidase moiety (amino acid residues 
6-1023). The black bar indicates an amino acid exchange (R +P) for 
amino acid residue 311 of BFDV-VP2. 
Fig. 2. Subcellular localization of BFDV-VP2 and SV40-VP2 fusion 
proteins determined by a histochemical assay (X-gal method). Fusion 
proteins were microinjected into the cytoplasm of HTC polykaryons 
at 37OC. The cells were fixed after different times. Subcellular location 
was determined by Wansmission microscopy. (A) SV40 VPf-wt 15 h, 
(B) BFDV-VP2-mtl 13 h, (C) BFDV-VP2-wtl 3 h, and (D) BFDV- 
VP2-wt2 10 h after microinjection, respectively. 
proteins were labeled with S-iodoacetamidofluoresccin (NAF; MO- 
lecular Probes, Eugene, USA) [12], and the distribution of proteins 
was determined after microinjection by microfluorimetry [12,16,17] at 
various time points. 
3. RESULTS AND DISCUSSION 
In kinetic determinations of the subcellular localiza- 
tion of fusion proteins (Fig. 1) by the X-gal assay, SV40- 
VPZ-wt was completely accumulated in the nucleus 15 
h after injection (Fig. 2A), whereas BFDV-VP%wtl was 
already accumulated in the nucleus after 3 h (Fig. 26). 
In contrast to the wild type proximal sequence of 
BFDV-VP2, both a mutant variant thereof (R3” -+ P; 
BFDV-VP2-mtl) and a fusion protein containing the 
distal sequence of basic amino acid residues instead of 
the 308-317 sequence (BFDV-VP2-wt2) resulted in cy- 
toplasmic localization of the respective proteins even 13 
or 10 h after microinjection, respectively (Fig. 2B,D). 
Nuclear accumulation kinetics were studied by sco- 
ring microinjected Vero cells for a fusion protein distri- 
bution either as cytoplasmic, approximately equal cyto- 
plasmic and nuclear, predominantly nuclear, or comple- 
tely nuclear localization of the fusion proteins after var- 
ious incubation times (Fig. 3). The results show clearly 
that BFDV-VP2-wt 1 was completely nuclear localized 
within 3 h (tyZ = 1.5 h, Fig. 3B) whereas SV40-VP2-wt 
nuclear accumulation was maximal at 15 h (Fig. 3A). 
No nuclear accumulation of BFDV-VP2-wt2 was ob- 
served up to 16 h (Fig, 3C). 
For more detailed studies of nuclear transport kine- 
tics with increased time resolution, fluorescence labelled 
fusion proteins were employed. Twenty-six minutes 
after cytoplasmic microinjection in HTC polykaryons 
the nucleocytoplasmic fluorescence ratio F,,,, was 1.45 
Z!I 0.15 (mean f SD, n = 4) for BFDV-VP%wt 1. In 
contrast, BFDV-VP&mtl showed only a value of F”,c 
= 0.44 f 0.07 (mean rf: SD, n = 6) The F,,c value for 
SV40-VP2 was 0.46 -C 0.09 (mean -C SD, n = 5). No 
differences were observed between HTC and Vero cells. 
In summary, our data indicate, that amino acid residues 
308-317 (VPKRKRKLPT) of BFDV are responsible 
for nuclear localization of fusion proteins BFDV-VP2 
and BFDV-VP3 at !Ggher rates than the SV40-VP2 
signal sequence. The crucial role of arginine 311 of 
BFDV-VP%wt for nuclear transport was demonstrated 
through exchange of arginine-311 by proline, which 
completely abolished nuclear transport of the hybrid 
protein. The second cluster of basic residues in BFDV- 
VP2 corresponding to amino acid residues 326-340 
(PSKRRYRGVRRKVRS), however, was not able to 
induce nuclear transport of P-galactosidase fusion pro- 
teins. Amino acid residues 308-315 of BFDV-VP2 are 
very similar to residues 317-324 of SV40-VP2 and show 
the NLS consensus sequence motif X-X-K-K/R-X-K/R 
discussed in a review by Roberts [g]. Roberts et al. [3] 
as well as Wychowski et al. [4] have shown that SV40- 
VP2 sequences, harboring the chosen amino acid resi- 
dues in this study for the construct SV40 VPZwt are 
able to target cytoplasmic proteins poliovirus VP1 and 
pyruvate kinase respectively into the nucleus. Surpris- 
ingly, transport into the nucleus of BFDV-VP2-wt 1 was 
much faster than that of a fusion protein carrying the 
NLS of SV40-VP2 3 17-PNKKKRKLSR-326. In a pre- 
vious study [13] we have shown that the nuclear trans- 
port kinetics of the NLS of SV 40 T-antigen is enhanced 
by a casein kinase II site flanking the NLS. Within the 
flanking sequences of the NLS of YV40-VP2 there is no 
7 
Volume 29 1, number 1 FEBS LETTERS October 1991 
proteins used in this study. Therefore differences ob- 
served in the rates of translocation have to be due to 
deviations in the two signal sequences and their inune- 
diate vicinities, aud the BFBV-VP2 signal may be 
somewhat closer to an ideal nuclear location signal than 
the SV40-VP2 sequence. 
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